Several single nucleotide polymorphisms (SNPs) are known to increase the risk of developing HT; much of this genetic variation concerns genes that are either thyroid-specific genes or are involved in autoimmunity, inflammation and/or cellular defense against stress (e.g., IL-1β, IL-6, and TNF) [38]. The gene discussed is IL1B; the disease is hematocrit.